# pleural mesothelioma stages

Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy - PubMed » The trimodality therapy concept with RP demonstrates promising results in terms of long-term survival, morbidity and mortality. We propose that a surgical philosophy of limiting the procedure related morbidity while achieving comparable cytoreductive results allows patients to maintain physiological … Pubmed.ncbi.nlm.nih.gov

Heparin in Preventing Blood Clots in Patients with Prostate Cancer after Surgery » Heparin in Preventing Blood Clots in Patients with Prostate Cancer after Surgery - NCT03006562 Cancer.gov

Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma - PubMed » It was possible to achieve a macroscopic complete resection using lung-sparing surgery in 97% of these patients with stage III/IV disease. The survival we observed with this approach was unusually long for the patients with the epithelial subtype but, interestingly, the PFS was not. The reason for t … Pubmed.ncbi.nlm.nih.gov

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma » Purpose We conducted a two-center phase II study to determine the safety of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) after chemotherapy and pleurectomy-decortication (P/D) as part of a multimodality lung-sparing treatment. Patients and Methods Patients received up to four cycles of pemetrexed plus platinum. If feasible, P/D was performed. Hemithoracic IMPRINT was administered to a planned dose of 50.4 Gy in 28 fractions. The primary end point was the incidence of grade 3 or greater radiation pneumonitis (RP). Results A total of 45 patients were enrolled; 18 were not evaluable (because of disease progression before radiation therapy [RT], n = 9; refusal of surgery or RT, n = 5; extrapleural pneumonectomy at time of surgery, n = 2; or chemotherapy complications, n = 2). A total of 26 patients received pemetrexed plus cisplatin, 18 received pemetrexed plus carboplatin, and four received a combination. Thirteen patients (28.9%) had a partial response, 15 patients (33.3%) experienced di Ascopubs.org

Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma† » AbstractOBJECTIVES. The role of radical pleurectomy (RP) in the management of IMIG stage III in malignant pleural mesothelioma (MPM) remains controversial. The Dx.doi.org

Stage I-III Malignant Pleural Mesothelioma » Patients with Stage 1-3 malignant pleural mesothelioma have cancer limited to one side of the chest, which can typically be removed surgically. Other treatment options include radiation therapy, chemotherapy, or a combination of multiple therapies (a multi-modal approach). Texasoncology.com